These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11367483)

  • 21. Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or continuing with three-times-daily indinavir-based therapy.
    Badía X; Podzamczer D; Moral I; Roset M; Arnaiz JA; Loncà M; Casiró A; Rosón B; Gatell JM;
    Antivir Ther; 2004 Dec; 9(6):979-85. PubMed ID: 15651756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of HIV-associated lipodystrophy.
    Wanke C
    AIDS Clin Care; 2000 Dec; 12(12):100. PubMed ID: 12211161
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapy side effects update.
    Proj Inf Perspect; 1998 Sep; (25):11-2. PubMed ID: 11365837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unsolved mystery of fat redistribution.
    STEP Perspect; 1999; 99(1):6-7. PubMed ID: 11367164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress toward a once daily regimen. (HA)ART--the art of antiretroviral therapy].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():78-9. PubMed ID: 11373790
    [No Abstract]   [Full Text] [Related]  

  • 26. The psychology of compliance.
    Condor B
    Posit Aware; 1997; 8(2):18-20. PubMed ID: 11364453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clearinghouse: HIV drug adherence.
    Focus; 1998 Feb; 13(3):4-5. PubMed ID: 11365168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Once-daily therapies.
    Carey D
    J HIV Ther; 2003 Feb; 8(1):7-11. PubMed ID: 12840708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New ethical obligations accompany new HIV drugs, conference told.
    Silversides A
    CMAJ; 1999 Jul; 161(2):187. PubMed ID: 10439830
    [No Abstract]   [Full Text] [Related]  

  • 30. Obstacles to treatment success.
    Cadman J
    GMHC Treat Issues; 1998 Oct; 12(10):8-10. PubMed ID: 11365904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twice-a-day Crixivan study discontinued.
    Newsline People AIDS Coalit N Y; 1998; ():31. PubMed ID: 11367502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follow PI doses or don't prescribe them at all, researchers say.
    AIDS Alert; 1997 Apr; 12(4):37-40. PubMed ID: 11364144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study to track benefits of compliance intervention.
    AIDS Alert; 1999 Feb; 14(2):23-4. PubMed ID: 11366176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipodystrophy--nukes vs. protease inhibitors.
    TreatmentUpdate; 2001 Jul; 13(3):5-6. PubMed ID: 11569989
    [No Abstract]   [Full Text] [Related]  

  • 35. Would use of specialists improve patient care?
    AIDS Alert; 1998 Aug; 13(8):87-9. PubMed ID: 11365648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interview with Prof. Reinhold E. Schmidt. Important selection criteria: tolerance and simplicity]].
    Schmidt RE
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():84-5. PubMed ID: 16385889
    [No Abstract]   [Full Text] [Related]  

  • 37. Considerations in selecting protease inhibitor therapy.
    Boyle BA; Elion RA; Moyle GJ; Cohen CJ
    AIDS Rev; 2004; 6(4):218-25. PubMed ID: 15700620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.
    Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ
    J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Switch" studies for people with lipodystrophy.
    Proj Inf Perspect; 2000 Aug; (30):9. PubMed ID: 12171017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Another take on when to start and how to succeed.
    Friedland GH
    AIDS Clin Care; 2001 Sep; 13(9):82. PubMed ID: 11547600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.